The official journal of CSACI
Citation: Allergy, Asthma & Clinical Immunology 2006 2:1
Page 22 of 22
Citation: Allergy, Asthma & Clinical Immunology 2006 2:1
The possibility of producing local hyposensitization by administering allergens via mucosal routes was envisaged at the beginning of 1900, and local nasal immunotherapy has been extensively studied since the 1...
Citation: Allergy, Asthma & Clinical Immunology 2006 2:117
With the judicious use of inhaled corticosteroids, β2 agonists, and leukotriene modifiers, most patients with asthma are easily controlled and managed. However, approximately 5% of asthmatics do not respond to st...
Citation: Allergy, Asthma & Clinical Immunology 2006 2:109
Neutrophils are critical inflammatory cells that cause tissue damage in a range of diseases and disorders. Being bone marrow-derived white blood cells, they migrate from the bloodstream to sites of tissue infl...
Citation: Allergy, Asthma & Clinical Immunology 2006 2:98
The aggregation of high-affinity immunoglobulin E (IgE) receptors (FcεRI) on mast cells is a critical event in the initiation of an allergic reaction. Coengagement of FcεRI with immunoglobulin G (IgG) low-affi...
Citation: Allergy, Asthma & Clinical Immunology 2006 2:87
Adverse food reactions are abnormal responses to ingested foods. Reactions vary from immunologic to nonimmunologic immune reactions and can be either immunoglobulin E (IgE) mediated or non-IgE mediated. Food-i...
Citation: Allergy, Asthma & Clinical Immunology 2006 2:78
The medical history is the gateway to the diagnosis of occupational asthma. The medical history should indicate whether a patient's asthma began during a work period and whether the asthma worsens during work ...
Citation: Allergy, Asthma & Clinical Immunology 2006 2:74
Complementary and alternative medicine and dietary supplements are often used by patients. A detailed examination of each preparation used by four patients was carried out. Seven such preparations with the pot...
Citation: Allergy, Asthma & Clinical Immunology 2006 2:68
To retrospectively examine the relation between skin test reactivity, venom-specific immunoglobulin E (IgE) antibody levels, and severity of clinical reaction in patients with insect venom allergy.
Citation: Allergy, Asthma & Clinical Immunology 2006 2:62
Citation: Allergy, Asthma & Clinical Immunology 2006 2:47
Guidelines for the diagnosis and management of asthma have been published over the last 15 years; however, there has been little focus on issues relating to asthma in childhood. Since the last revision of the ...
Citation: Allergy, Asthma & Clinical Immunology 2006 2:24
Angioedema is a common presentation with a broad differential, including rare disorders with which an allergist must be familiar. Our objective was to report a case of swelling of the hands and feet mimicking ...
Citation: Allergy, Asthma & Clinical Immunology 2006 2:20
There is increased emphasis on the role of indoor allergens in asthma.
Citation: Allergy, Asthma & Clinical Immunology 2006 2:11
The objective of this study was to investigate the prevalence and severity of asthma, rhinitis, and atopic eczema in schoolchildren from southern Brazil. A cross-sectional study was carried out with the Intern...
Citation: Allergy, Asthma & Clinical Immunology 2006 2:3
Citation: Allergy, Asthma & Clinical Immunology 2006 2:1
This article summarizes and provides commentary regarding guidelines on the administration of immunotherapy (IT) for allergic airway disease. Recent investigations have provided important insights into the imm...
Citation: Allergy, Asthma & Clinical Immunology 2005 1:161
Pediatric hemophagocytic syndrome (HS) is a severe and often fatal clinical disorder. This syndrome is frequently unrecognized, and thus, affected children may receive suboptimal management, leading to an incr...
Citation: Allergy, Asthma & Clinical Immunology 2005 1:142
Little is known about the distribution of lymphocyte phenotypes in young children and the association specific phenotypes may have with respiratory illnesses. The objective of this study was to describe lympho...
Citation: Allergy, Asthma & Clinical Immunology 2005 1:135
For patients who require replacement therapy for primary immunodeficiency, subcutaneous infusions of immunoglobulin G (IgG) may be preferable to intravenous infusions for several reasons. However, at present, ...
Citation: Allergy, Asthma & Clinical Immunology 2005 1:120
Citation: Allergy, Asthma & Clinical Immunology 2005 1:117
Citation: Allergy, Asthma & Clinical Immunology 2005 1:101
Over the last few years, the evidence of links between rhinitis and asthma has been strengthened. This has led to the introduction of the concept of united airway disease. Rhinitis and asthma appear to be inte...
Citation: Allergy, Asthma & Clinical Immunology 2005 1:81
More and more studies are demonstrating interactions between the nervous system and the immune system. However, the functional relevance of this interaction still remains to be elucidated. Such associations ha...
Citation: Allergy, Asthma & Clinical Immunology 2005 1:65
Asthma is a very common disorder that still causes significant morbidity and mortality. A high percentage of individuals with asthma also experience exercise-induced bronchoconstriction (EIB). This article rev...
Citation: Allergy, Asthma & Clinical Immunology 2005 1:60
Hypersensitivity to bloodworms (chironomid larvae) leading to asthma and other related allergic disorders is becoming common in individuals who keep or work with fish due to the increased use of bloodworms as ...
Citation: Allergy, Asthma & Clinical Immunology 2005 1:58
Both B-lymphoblastoid cell lines and tonsillar B lymphocytes express receptors for platelet-activating factor (PAF). In lymph node germinal centres, B lymphocytes interact with follicular dendritic cells (FDCs...
Citation: Allergy, Asthma & Clinical Immunology 2005 1:49
Citation: Allergy, Asthma & Clinical Immunology 2005 1:48
Numerous recombinant therapies are being investigated for the treatment of asthma. This report reviews the current status of several of these novel agents. Anti-immunoglobulin (Ig)E (omalizumab, Xolair) marked...
Citation: Allergy, Asthma & Clinical Immunology 2004 1:34
Current guidelines for the diagnosis and treatment of osteoporosis do not address the risks to bone density and the likelihood of fracture that may be associated with inhaled corticosteroid treatment for asthm...
Citation: Allergy, Asthma & Clinical Immunology 2004 1:28
The surgical management of chronic rhinosinusitis has evolved considerably in the last decade. We currently have a more refined understanding of the various disease entities that make up the generic diagnosis ...
Citation: Allergy, Asthma & Clinical Immunology 2004 1:21
Citation: Allergy, Asthma & Clinical Immunology 2004 1:20
Citation: Allergy, Asthma & Clinical Immunology 2004 1:11
The official journal of CSACI
Speed
81 days to first decision for reviewed manuscripts only
74 days to first decision for all manuscripts
169 days from submission to acceptance
14 days from acceptance to publication
Citation Impact
2.104 - 2-year Impact Factor
2.339 - 5-year Impact Factor
0.988 - Source Normalized Impact per Paper (SNIP)
0.771 - SCImago Journal Rank (SJR)
Usage
988,631 Downloads
1,032 Altmetric mentions